UroX Biomarker Bladder Cancer Study
Research type
Research Study
Full title
Evaluation of UroX™ biomarker screening test in the investigation of bladder cancer from urine samples – a single site pilot study
IRAS ID
253585
Contact name
Nikhil Vasdev
Contact email
Sponsor organisation
East and North Hertfordshire NHS Trust
Duration of Study in the UK
1 years, 6 months, 1 days
Research summary
This is a prospective observational study looking at urine samples from participants under referral for a standard of care investigative cystoscopy and biopsy.
The study aims to test if the UroX™ biomarker (a measurable indicator of a biological condition) can be detected in urine samples from participants who may later test positive following a biopsy for bladder cancer. The study aims to assess the value of the biomarker as a screening tool for bladder cancer.
Patients with and those without bladder cancer are required for this study.
REC name
East of England - Essex Research Ethics Committee
REC reference
18/EE/0395
Date of REC Opinion
20 Dec 2018
REC opinion
Favourable Opinion